Literature DB >> 3111561

Isolation, characterization, and localization of glycosaminoglycans in rabbit bone marrow.

K Oguri, E Okayama, B Caterson, M Okayama.   

Abstract

The glycosaminoglycans that exist in rabbit bone marrow were analyzed chemically, and their in situ localization was studied immunohistochemically. Femoral bone marrow of 3-month-old rabbits was defatted with organic solvents. Glycosaminoglycans were prepared from the defatted tissue after its digestion with pronase, treatment with mild alkali, and then digestion with DNase-I. The tissue contained glycosaminoglycans equivalent to 195 mg of hexosamine per femur, which accounted for 27.3% of the total hexosamine in the tissue. Studies with hyaluronidase from Streptomyces hyalurolyticus and chondroitinase ABC showed that the glycosaminoglycans were composed of hyaluronic acid (16% of the total glycosaminoglycan) and chondroitin 6-sulfate (79%). The chondroitin 6-sulfate was separated on Bio-Gel A-0.5m gel into two molecular species with mol wt of greater than 12,000 (Kd greater than 0.2) and approximately 8,000 (Kd = 0.47). Bone marrow digested with chondroitinase ABC and then treated with three monoclonal antibodies 4/8/9-A-2, 5/6/3-B-3, and 5/6/1-B-5, which were specific for unsaturated 4-sulfated, 6-sulfated, and nonsulfated disaccharide structures, respectively, at the nonreducing end of chondroitin sulfate chains, reacted with only 5/6/3-B-3. This result indicated that the chondroitin sulfate, isomer in the bone marrow is chondroitin 6-sulfate, consistent with the biochemical results. The chondroitin 6-sulfate was localized mainly in the extracellular compartment and was considered to be involved in construction of the hemopoietic microenvironment in the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111561

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Fell-Muir Lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others.

Authors:  Bruce Caterson
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

2.  Observations on the haemopoietic response to critical illness.

Authors:  R J Amos; M Deane; C Ferguson; G Jeffries; C J Hinds; J A Amess
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 3.  The extracellular matrix of the hematopoietic microenvironment.

Authors:  G Klein
Journal:  Experientia       Date:  1995-09-29

4.  Deficient differentiation of mast cells in the skin of mi/mi mice. Usefulness of in situ hybridization for evaluation of mast cell phenotype.

Authors:  T Kasugai; K Oguri; T Jippo-Kanemoto; M Morimoto; A Yamatodani; K Yoshida; Y Ebi; K Isozaki; H Tei; T Tsujimura
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 5.  Evolution of the Marrow Adipose Tissue Microenvironment.

Authors:  Clarissa S Craft; Erica L Scheller
Journal:  Calcif Tissue Int       Date:  2016-07-01       Impact factor: 4.333

6.  Fate of ciliated epidermal cells during early development of Xenopus laevis using whole-mount immunostaining with an antibody against chondroitin 6-sulfate proteoglycan and anti-tubulin: transdifferentiation or metaplasia of amphibian epidermis.

Authors:  S Nishikawa; J Hirata; F Sasaki
Journal:  Histochemistry       Date:  1992-12

7.  Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials.

Authors:  H Nakanishi; K Oguri; K Yoshida; N Itano; K Takenaga; T Kazama; A Yoshida; M Okayama
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

8.  RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues.

Authors:  Jasper J van Gemst; Markus A Loeven; Mark J J de Graaf; Jo H M Berden; Ton J Rabelink; Cornelis H Smit; Johan van der Vlag
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

9.  Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia.

Authors:  Miho Senda; Ryuichi Fukuyama; Tetsuro Nagasaka
Journal:  J Clin Pathol       Date:  2016-03-07       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.